VEDOLIZUMAB

UNII: 9RV78Q2002
Preferred Substance Name: VEDOLIZUMAB

943609-66-3
ENTYVIO
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTEGRIN LPAM-1 (LYMPHOCYTE PEYER'S PATCH ADHESION MOLECULE 1)) (HUMAN-MUS MUSCULUS HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS .KAPPA.-CHAIN, DIMER
LDP02
LDP-02
MLN0002
MLN-0002
MLN02
MLN-02
VEDOLIZUMAB [INN]
VEDOLIZUMAB [JAN]
VEDOLIZUMAB [MART.]
VEDOLIZUMAB [MI]
VEDOLIZUMAB [PURPLE BOOK CDER]
VEDOLIZUMAB [USAN]
VEDOLIZUMAB [VANDF]
VEDOLIZUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

VEDOLIZUMAB

Synonyms and Mappings

Resources

Note